Skip to main content
. 2019 Sep 18;15(3):328–337. doi: 10.5114/aic.2019.87887

Table II.

Procedural data and stent type

Parameter DES (n = 148) BMS (n = 280) P-value
Right VA, n (%) 79 (53.4) 118 (42.1) 0.037
Left VA, n (%) 71 (48) 162 (57.9)
Transradial approach, n (%) 10 (6.8) 16 (5.9) 0.668
Contralateral VA occlusion, n (%) 13/140 (9.3) 23/260 (8.9) 0.884
V0/V1 segment, n 148 275 0.041
Old generation DES, n (% of DES):
 Sirolimus-eluting stent 14 (9.4) n/a
 Paclitaxel-eluting stent 8 (5.3) n/a
Second generation DES, n (% of DES):
 Everolimus-eluting stent 57 (38) n/a
 Biolimus-eluting stent 35 (23.3) n/a
 Zotarolimus-eluting stent 36 (24) n/a
Stainless-steel, n (%) n/a 139 (49.6)
Cobalt-chromium, n (%) n/a 123 (44)
Platinum-chromium, n (%) n/a 18 (6.4)
Stenosis severity – angio (%):
 Pre-treatment, mean ± SD 86.0 ±9.7 84.1 ±9.4 0.056
 Post-treatment, mean ± SD 2.7 ±5 4.3 ±6.9 0.014
Stent diameter, mean ± SD [mm] 3.4 ±0.5 4.2 ±0.8 < 0.001
Stent length, mean ± SD [mm] 12 ±3.9 11.9 ±2.7 0.323
Direct stenting, n (%) 110 (73.3) 221 (78.9) 0.279
Maximum inflation pressure, mean ± SD [atm] 11.6 ±2.4 11.7 ±2.4 0.265
Maximum post-dilatation balloon pressure, mean ± SD [atm] 16.7 ±3.2 16.2 ±3.2 0.056
Simultaneous VAS + SAS, n (%) 6 (4) 9 (6.1) 0.653

Two stents implanted to cover one lesion. Continuous data are presented as the mean ± standard deviation; categorical data are given as the count and percentage. VAS + SAS – vertebral and subclavian artery stenting.